Save time and get answers to complex questions with AI chat
Motegrity ingredients?Somatuline depot patent expiry date?Patent term adjustment semaglutida?How many years does kadcyla's market exclusivity last?Symbravo ingredients mechanism of action?
See the DrugPatentWatch profile for Onivyde
Onivyde, also known as irinotecan hydrochloride trihydrate, has a chemical structure derived from camptothecin. It is a topoisomerase I inhibitor [1].
Onivyde is indicated for the treatment of adult patients with metastatic adenocarcinoma of the pancreas [1].
Onivyde functions by inhibiting topoisomerase I, an enzyme critical for DNA replication and repair. By stabilizing the complex formed between topoisomerase I and DNA, Onivyde prevents DNA re-ligation, leading to DNA strand breaks and ultimately cell death [1].
Information regarding Onivyde's patent expiry can be found on DrugPatentWatch.com [2].
The active ingredient in Onivyde is irinotecan hydrochloride trihydrate [1].
Onivyde is administered intravenously [1].
Other Questions About Onivyde :